Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Famotidine and Efavirenz on Daridorexant PK in Healthy Males
NCT04390334Phase 1Completed
- Sponsor
- Idorsia
- Start
- May 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of daridorexant in Insomnia (4 arms), sponsored by Idorsia. Primary endpoints: Maximum Plasma Concentration, Time to Reach Cmax and 3 more. Started May 2020; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT04390334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04390334.